Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

DDX26B Activators

DDX26B Activators would represent a class of chemical substances that specifically interact with and enhance the activity of the DDX26B protein. DDX26B is presumed to be a member of the DEAD-box protein family, which are putative RNA helicases known to be involved in various aspects of RNA metabolism, including transcription, splicing, ribosome assembly, and RNA decay. DEAD-box proteins typically utilize ATP to unwind RNA duplexes, an essential process for the proper functioning of RNA-related cellular activities. Activators of DDX26B, therefore, would likely function by increasing the RNA helicase activity of the protein. This could be achieved by facilitating ATP binding or hydrolysis, stabilizing the protein in a conformation that is more conducive to RNA binding or unwinding, or enhancing the interaction between DDX26B and its RNA substrates or other protein partners involved in RNA processing.

The identification and study of DDX26B Activators would involve comprehensive biochemical and biophysical approaches. Structural biology techniques such as X-ray crystallography or NMR spectroscopy could be employed to determine the three-dimensional structure of DDX26B, providing insights into potential binding sites for activators. This structural knowledge would guide the synthesis of small molecules that might fit into these sites and modulate the protein's activity. Once potential activators are synthesized, their effect on DDX26B activity would be measured using in vitro assays. These assays could monitor the helicase activity of DDX26B by observing the unwinding of RNA duplexes in the presence of ATP and potential activators. Additionally, the binding affinity and kinetics of these molecules with DDX26B could be evaluated using surface plasmon resonance or isothermal titration calorimetry. Through such rigorous scientific evaluation, a detailed understanding of how DDX26B Activators influence the function of this RNA helicase would be developed, illuminating their role in RNA metabolism.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

As a chemotherapeutic agent known to induce DNA damage, doxorubicin might upregulate INTS6L expression as part of the DNA damage response.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin causes DNA crosslinking and could stimulate INTS6L expression through activation of the DNA repair pathway.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

This topoisomerase II inhibitor can lead to DNA damage and potential upregulation of genes involved in the DNA damage response, such as INTS6L.

L-Mimosine

500-44-7sc-201536A
sc-201536B
sc-201536
sc-201536C
25 mg
100 mg
500 mg
1 g
$36.00
$88.00
$220.00
$436.00
8
(2)

Mimosine induces cell cycle arrest and may affect the expression of genes like INTS6L that are related to RNA processing.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea induces replication stress and could upregulate INTS6L expression as part of the cellular stress response.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

As an inhibitor of topoisomerase I, camptothecin introduces DNA breaks, possibly influencing INTS6L expression.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine affects nucleic acid metabolism and could hypothetically alter the expression of INTS6L.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate impacts nucleotide biosynthesis and could modulate the expression of genes associated with RNA processing.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Known to inhibit transcription, actinomycin D might influence INTS6L expression by acting on RNA polymerase II.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C and could alter gene expression profiles, which might affect INTS6L.